<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S2188 IS: Rare Disease Innovation Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-10-21</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>114th CONGRESS</congress><session>1st Session</session>
		<legis-num>S. 2188</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20151021">October 21, 2015</action-date>
			<action-desc><sponsor name-id="S377">Mr. Gardner</sponsor> (for himself and <cosponsor name-id="S356">Mr. Donnelly</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act with respect to the humanitarian device
			 exemption.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header>
 <text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Rare Disease Innovation Act</short-title></quote>.</text>
		</section><section id="id9FD23889E57049B3BE7A11C844E21430"><enum>2.</enum><header>Humanitarian device exemption application</header>
 <subsection id="id0fd1d7f4c29d4edaab47dd345202759c"><enum>(a)</enum><header>In general</header><text>Section 520(m) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360j">21 U.S.C. 360j</external-xref>) is amendedâ€”</text> <paragraph id="id9e9968b8ca4e484283ddcf1c4e2a8bc2"><enum>(1)</enum><text>in paragraph (1) by striking <quote>fewer than 4,000</quote> and inserting <quote>not more than 8,000</quote>;</text>
 </paragraph><paragraph id="iddcf71f76290346cc85f8f9240237de33"><enum>(2)</enum><text>in paragraph (2)(A) by striking <quote>fewer than 4,000</quote> and inserting <quote>not more than 8,000</quote>; and</text> </paragraph><paragraph id="id8b075a3d921d4525a3c2ed2329c0dc83"><enum>(3)</enum><text>in paragraph (6)(A)(ii), by striking <quote>4,000</quote> and inserting <quote>8,000</quote>.</text>
 </paragraph></subsection><subsection id="idfa510719083c4b3fbbc5030c8523260d"><enum>(b)</enum><header>Guidance document on probable benefit</header><text>Not later than 18 months after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall publish a draft guidance document that defines the criteria for establishing <quote>probable benefit</quote> as that term is used in section 520(m)(2)(C) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360j">21 U.S.C. 360j(m)(2)(C)</external-xref>).</text>
 </subsection><subsection id="idCCCE3EAFA54F424584A95394151505B1"><enum>(c)</enum><header>Reports to Congress</header><text>Five years after the date of enactment of this Act and every 5 years thereafter, the Secretary of Health and Human Services shall submit to Congress a report on the effect of the amendments made by subsection (a).</text></subsection></section></legis-body>
</bill>


